Predictions
Amazon.com Inc.
Start price
Target price
Perf. (%)
€125.28
11.08.23
11.08.23
€209.65
11.08.24
11.08.24
22.83%
12.08.24
12.08.24
Amazon.com Inc.
Start price
Target price
Perf. (%)
€125.28
11.08.23
11.08.23
€209.65
11.08.24
11.08.24
22.83%
12.08.24
12.08.24
Alphabet Inc. A
Start price
Target price
Perf. (%)
€117.74
11.08.23
11.08.23
€127.61
11.08.24
11.08.24
28.01%
12.08.24
12.08.24
Alphabet Inc. A
Start price
Target price
Perf. (%)
€117.74
11.08.23
11.08.23
€127.61
11.08.24
11.08.24
28.01%
12.08.24
12.08.24
Alphabet Inc. A
Start price
Target price
Perf. (%)
€117.74
11.08.23
11.08.23
€127.61
11.08.24
11.08.24
28.01%
12.08.24
12.08.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€127.30
11.08.23
11.08.23
€185.95
11.08.24
11.08.24
-20.23%
12.08.24
12.08.24
RCI Hospitality Holdings Inc
Start price
Target price
Perf. (%)
€61.50
11.08.23
11.08.23
€114.85
11.08.24
11.08.24
-33.17%
12.08.24
12.08.24
Boston Scientific
Start price
Target price
Perf. (%)
€46.63
11.08.23
11.08.23
€55.60
11.08.24
11.08.24
50.12%
12.08.24
12.08.24
MeiraGTx Holdings
Start price
Target price
Perf. (%)
€5.50
11.08.23
11.08.23
€37.37
11.08.24
11.08.24
-29.09%
12.08.24
12.08.24
Cyberark Software
Start price
Target price
Perf. (%)
€145.70
11.08.23
11.08.23
€173.19
11.08.24
11.08.24
70.35%
12.08.24
12.08.24
scPharmaceuticals
Start price
Target price
Perf. (%)
€7.15
11.08.23
11.08.23
€16.41
11.08.24
11.08.24
-45.73%
12.08.24
12.08.24
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.59
11.08.23
11.08.23
€31.90
11.08.24
11.08.24
82.22%
12.08.24
12.08.24
B2gold Corp.
Start price
Target price
Perf. (%)
€2.80
11.08.23
11.08.23
-
11.08.26
11.08.26
-2.14%
15.04.24
15.04.24
Could be very worthwhile Investment >20% year
Below average Marketposition
Very high cyclical dependencies
Unknown brand
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€2.68
11.08.23
11.08.23
-
11.08.26
11.08.26
26.17%
22.11.23
22.11.23
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected